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Abstract
Testing gene-based associations is the fundamental approach to identify genetic
associations in sequencing studies. The best-known approaches include Burden and
Sequence Kernel Association Tests (SKAT). The gene-traits associations are often
complex due to population heterogeneity, gene-environmental interactions, and var-
ious other reasons. The mean-based tests, including Burden and SKAT, may miss
or underestimate some high-order associations that could be scientifically interesting.
In this paper, we propose a new family of gene-level association tests, which integrate
quantile rank score processes while combining multiple weighting schemes to accom-
modate complex associations. The resulting test statistics have multiple advantages.
They are as efficient as the mean-based SKAT and Burden test when the associations
are homogeneous across quantile levels and have improved efficiency for complex and
heterogeneous associations. The test statistics are distribution-free, and could hence
accommodate a wide range of distributions. They are also computationally feasible.
We established the asymptotic properties of the proposed tests under the null and
alternative hypothesis and conducted large scale simulation studies to investigate its
finite sample performance. We applied the proposed tests to Metabochip data to
identify genetic associations with lipid traits and compared the results with those of
the the Burden and SKAT tests.
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1 Introduction
The increasing efficiency in generating large scale genome sequencing studies such as
TOPMed (Taliun et al., 2019) has motivated the development of novel statistical tests
for association testing with genetic variants discovered in sequencing data (Morgenthaler
and Thilly, 2007; Li and Leal, 2008; Morris and Zeggini, 2010; Wu et al., 2011, 2013; Chen
et al., 2019; He et al., 2019; Ionita-Laza et al., 2011). As those studies genotyped a large
number of variants and most of them have low population frequencies, the primary test of
interest is to test whether a group of variants within a region, such as a gene or noncoding
region, are associated with a phenotype of interest. The existing tests include the Bur-
den tests and the sequence kernel association tests (SKAT). The Burden tests aggregate
mutation burden across the variants within a gene or region and then tests for association
between the mutational burden and a phenotype of interest. Burden tests assume that
genetic variants associated with the phenotype are in the same direction and with similar
magnitude of effect (Bomba et al., 2017). The SKAT tests (Wu et al., 2011; Lee et al.,
2012) relax these assumptions by allowing a mixture of risk and protective variants, and
allowing only a small percentage of causal variants in a region. Both tests are commonly
used in the literature. Extensions to test the joint effect of rare and common variants in a
gene have also been proposed Li and Leal (2008); Ionita-Laza et al. (2013).
These existing tests evaluate whether genetic variants are associated with differences
in the mean phenotype values. However, genetic associations can be complex, and genetic
variants can influence other aspects of the phenotype distribution than the mean. For
instance, Yang et al. (2012) showed that an SNP at the FTO gene locus is not only as-
sociated with the mean of body mass index (BMI) but also with its variance. Similarly,
variance quantitative trait loci (vQTLs) have been identified (Brown et al., 2014; Pare´ et al.,
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2010). Testing for effects on higher-order moments is important as it can lead to new ge-
netic discoveries, and point to more complex effects such as gene-gene or gene-environment
interactions (Pare´ et al., 2010; Wang et al., 2019).
One way to investigate complex genetic associations is to use quantile regression (Koenker
and Bassett, 1978) to estimate and compare the conditional quantile functions of a trait
given genetic variants while adjusting for covariates. Such quantile based approaches have
been applied in several genetic studies (Briollais and Durrieu, 2014; Beyerlein et al., 2011),
and reported heterogeneous quantile-specific genetic effects on many human complex traits.
For example, Beyerlein et al. (2011) applied quantile regression to study the association
between BMI and eight selected genetic variants, and found that their effect on childhood
BMI is more pronounced among children with larger BMI. Song et al. (2017) also found
that the eQTLs (expression quantitative trait loci) with heterogeneous quantile effects are
associated with strong GWAS enrichment.
Despite these significant findings for common genetic variants, quantile-based associa-
tions have not been investigated for rare variants in sequencing studies. Here we propose
an efficient and distribution-free group-wise quantile association test for sequencing data.
We proposed a quantile regression model for gene-trait associations, which integrates the
entire regression quantile rank-score process (Gutenbrunner et al., 1993; Koenker et al.,
2010) with multiple weighting schemes, and adaptively combines them into test statistics
to identify gene-trait associations in sequencing data. The proposed test statistics extend
the classical SKAT and Burden tests for complex gene-trait associations. We call the new
tests Integrated Quantile RAnk Test(iQRAT), and establish their asymptotic properties
under both null and local alternative hypotheses. We extensively compared both asymp-
totic efficiency and empirical power of the proposed iQRAT tests with existing approaches
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and found that they are at least as efficient as the standard mean-based tests in the case
of homogeneous associations and has enhanced power for more complex and heterogeneous
associations. Besides, the proposed iQRAT tests are distribution-free, so that they can
accommodate a wide range of distributions, and are invariant to normalization transfor-
mations. Both are important considerations in genetic associations, as human complex
traits are often non-normal, and avoiding normalization helps to achieve transparent inter-
pretations and direct insights of gene-trait associations. We applied the proposed test in
Metabochip data (Voight et al., 2012) to identify genes associated with lipid traits.
The rest of the paper is organized as follows: we present the proposed methodology
and related properties in Section 2; in Section 3, we present a large scale simulation study
to investigate the type I error and power under various models; in Section 4, we analyze
data from the Metabochip for lipid traits; in Section 5, we discuss the advantages and
limitations of the proposed method. Proofs for the asymptotic results and more plots are
presented in the Supplementary Material.
2 Methodology
2.1 Notations and background
Throughout the paper, we denote (Yi,Xi,Ci), i = 1, ..., n as a random sample, where
Xi = (Xi1, . . . , Xip) is the p-dimensional genotype vector in a region (e.g., a gene) for the
ith individual, Yi is the trait value, and Ci = (Ci1, . . . , Ciq) is an q-dimensional covariate
vector for the ith individual. The genotype vector Xi can be a mixture of both rare and
common genetic variants. The goal is to determine whether any of the p genetic variants
is associated with the outcome Yi. The classical linear model for genetic associations can
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be written as
E(Yi|Xi, Ci) = α0 + Ciα + Xiβ, (1)
where β = (β1, . . . , βp)
> are regression coefficients for the p genetic variants. The hypothesis
of interest is H0 : β = 0, i.e. the mean of Yi is unrelated to Xi.
To test β = 0 in eq (1), the Burden and SKAT test statistics have been proposed (Wu
et al., 2011; Lee et al., 2012; Morgenthaler and Thilly, 2007; Li and Leal, 2008). They can
be written in the form
Qρ = (Y − µˆ0)>Kρ(Y − µˆ0),
where Y is the vector of the outcome Yi, µˆ0 is the vector of estimated means under the null
model (i.e all β’s equal to zero), Kρ = XWRρWX
>, Rρ = (1 − ρ)I + ρ11> specifies an
exchangeable correlation matrix, and W = diag(w1, . . . , wp) is a diagonal weight matrix.
The weights w1, . . . , wp are pre-determined and assigned to each genetic variant. The choice
of weights depends on individual application, according to the probability of these variants
to be functional and hence more likely to influence the trait. By default, the weights
are inversely proportional to the minor allele frequencies (MAF) of the variants. Other
functional scores such as CADD, DANN, FunSeq2, LINSIGHT, Eigen or FUN-LDA can
also be chosen (Kircher et al., 2014; Ionita-Laza et al., 2016; Quang et al., 2014; Huang
et al., 2017; Backenroth et al., 2018; Lu et al., 2016; Zhou and Troyanskaya, 2015). The
Burden test and the SKAT test are special cases for ρ = 1 and ρ = 0, respectively. They
can be written as
QSKAT =
p∑
j=1
w2j
[
n∑
i=1
(Yi − µˆi,0)Xij
]2
, QBurden =
[
p∑
j=1
wj
n∑
i=1
(Yi − µˆi,0)Xij
]2
.
The null distribution of QBurden is a scaled χ
2
1 distribution, and the null distribution of
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QSKAT follows a mixture of χ
2
1 distributions. The p values can be calculated based on the
method of Liu et al. (2009). See Section 3.3 for more details.
2.2 Proposed Integrated Quantile RAnk Test (iQRAT)
To test the genetic association across quantiles, we extend the mean model (1) to the
following conditional quantile model of Y given a genetic and covariate profile (X,C),
QYi(τ |Ci,Xi) = α0(τ) + Ciα(τ) + Xiβ(τ),∀τ ∈ (0,1), (2)
where β(τ) = (β1(τ), β2(τ), ..., βp(τ))
> is the p-dimensional quantile coefficient functions
associated with the gene Xi, α(τ) are those associated with the covariate Ci, α0(τ) is the
intercept function. One can view α0(τ) as the quantile function of Y when both X and C
are zero. In the rest of the paper, we call F (·) = α−10 (τ) the error distribution of Model
(2).
In a special case where X is coded as a binary indicator for the presence of a mutation,
the coefficient function β(τ) = QY (τ |X = 1,C)−QY(τ |X = 0,C) measures the change of
the quantile functions of Y due to the mutation in X. Let H(·) and G(·) be the distributions
of Y with and without mutation in X, β(τ) = H−1(τ)−G−1(τ) is equivalent to measuring
the distributional difference of Y induced by the mutation in X. The mean effect µ =
E(Y |X = 1) − E(Y |X = 0) can be obtained by integrating β(τ) over τ , i.e. as µ =∫ 1
0
β(τ)dτ =
∫ 1
0
(H−1(τ)−G−1(τ))dτ . When a mutation in X only leads to a location shift
in the distribution of Y , the quantile effect β(τ) is constant cross quantile levels, and is
identical to the mean effect. When a mutation in X changes the variance/dispersion of Y ,
one would observe larger quantile effects at the two tails but opposite directions. Due to the
resulting quantile crossing (i.e.,positive effect at the upper quantiles while negative effect
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at lower quantiles), mean-based association tests often fail to detect such associations. In
more complicated cases where a mutation in X changes both mean and variance of Y , or
only affects part of the distribution of Y , or the distribution of Y contains multiple modes,
mean-based associations may over-simplify the underlying biological functions. When X
is multivariate, e.g., a sequence of variants on a gene, the quantile coefficients β(τ) =
(β1(τ), ..., βp(τ))
> are non-zero, and its jth component βj(τ) is the marginal quantile effect
of the jth variant, i.e. we write βj(τ) = QY (τ |Xj = 1, C,X−j) − QY (τ |Xj = 0, C,X−j),
were X−j is the vector of genes excluding the jth variant.
Next, we propose a new group-wise quantile association test to test the hypothesis
H0 : β(τ) = 0, ∀ τ ∈ (0, 1),
i.e., whether the quantile function of Y is related to the genotypes X at any quantile level
τ ∈ (0, 1). We call the proposed test Integrated Quantile RAnk Test (iQRAT), and outline
the construction of the iQRAT in the following.
Step 1: Step 1: Estimate the null model, and construct individual quantile
rank score processes under the null model. Under the null hypothesis β(τ) = 0,
the conditional quantile of Y given X and C can be written as QY (τ |X,C) = Cα(τ).
We estimate the null model on all the estimable quantile levels by
α̂τk = arg minα
n∑
i=1
ρτk(Yi −Ciα),∀ k = 1, ..., kn,
where ρτ (u) = τ |u|I{u > 0} + (1 − τ)|u|I{u ≤ 0} is the quantile regression loss
function, and (τ1, ..., τkn) are kn estimable quantile levels. We use parametric linear
programming to estimate the entire quantile process with all the kn estimable quantile
levels given the data. We refer to Koenker et al. (1990); Gutenbrunner et al. (1993);
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Koenker et al. (2014) for technical details of parametric linear programming and
estimable quantile process. Similar as in Wei and Carroll (2009), we then estimate
the quantile coefficient function α(τ) by a linear spline expanded from the {α̂τk , k =
1, ..., kn}, and denote it as α̂n(τ). Next, we construct a quantile regression rank score
process by
âi(τ) = 1{Yi < Ciα̂n(τ)} − τ,
where 1{Yi < Ciα̂n(τ)} is a binary indicator whether Yi stays underneath the τ -th
estimated conditional quantile. If the null hypothesis β(τ) = 0 is true, we expect the
score function E(âi(τ)) = 0 for any τ ∈ (0, 1). A deviation from zero at any quantile
level τ suggests the existence of genetic associations.
Step 2: Integrate âi(τ) over τ with multiple weight functions. As âi(τ) indicates quantile-
specific associations, a natural way to measure the overall genetic association is to
integrate âi(τ) over quantile levels τ . We consider weighted integrations to enhance
the detection of heterogeneous associations.
Let ϕ : (0, 1) → R be a non-decreasing square-integratable function. We integrate
each âi(τ) over τ with respect to the ϕ(·) by φ̂ϕi =
∫ 1
0
âi(t)dϕ(t), i = 1, ..., n. Since
âi(t) is a piece-wise linear function, φ̂
ϕ
i can be written as
φ̂ϕi =
∫ 1
0
âi(t)dϕ(t) =
kn∑
j=1
âi(τj)− âi(τj−1)
τj − τj−1
∫ τj
τj−1
ϕ(t)dt.
The integrated rank score φ̂ϕ essentially accumulates the evidence across quantile
levels, and uses the first derivative ∂ϕ(t)/∂t as the weight function to assign different
weights at different quantile levels. When ϕ(t) is a linear function of t, the resulting
rank score φ̂ϕ is an unweighted average over quantile process, and hence is equivalent
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to the mean effect. Among them, we define ϕ1(t) = t as a special case, which is
known as Wilcoxon score function in the literature of rank-score tests (Gutenbrunner
and Jureckova´, 1992; Gutenbrunner et al., 1993; Koenker et al., 2010). To enhance
the detection of heterogeneous associations, we also consider two additional weight
functions ϕ(t) from Koenker et al. (2010). The first one is normal quantile func-
tion ϕ2(τ) = Φ
−1(τ), where Φ(·) is the standard normal distribution function. The
second one is the Lehmann score function ϕ3(τ) = − log(1 − τ) − 1. Figure 6 in
Supplymentary Material displays the functions ϕ1(t), ϕ2(t) and ϕ3(t). As indicated
by the figure, ∂ϕ2(t)/∂t is symmetric around the median with heavier weights at the
two tails. The resulting integrated rank scores,
∫ 1
0
âi(t)dϕ2(t), help identify genetic
effects on variance/dispersion. On the other hand, the first derivative of Lehmann
score, ∂ϕ3(t)/∂t, is asymmetric. It assigns acceleratingly heavier weights on the up-
per tail. The integrated score
∫ 1
0
âi(t)dϕ3(t) enhance the detection on a strong local
effect on the right tail. As each weight function captures certain type of commonly
observed and biologically-meaningful associations in genetics, we propose to integrate
the rank-score process using each of the three ϕ(t) functions, and then combine them
into a single test statistic as we discuss later in Section 2.3.
Step 3: Construct iQRAT statistics. The proposed iQRAT tests are based on the fol-
lowing key statistics:
Sϕ = n−1/2
n∑
i=1
X∗>i φ̂
ϕ
i , (3)
where X∗i is the genotype vector after being orthogonalized against the covariate
matrix. Let Cn be the n × m design matrix associated with the covariates, and
PC = Cn(C
>
nCn)
−1C>n is the projection matrix onto the linear space of Cn. X
∗
i
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is the ith row of the matrix X∗ = (I − PC)Xn, where Xn is the the n × p design
matrix associated with genotypes. The orthogonalization ensures the asymptotic
independence between the genetic association and covariates. The test statistic Sϕ is
in the category of rank-based statistics (Sidak et al., 1999; Gutenbrunner et al., 1993).
We propose two integrated quantile rank test (iQRAT) statistics that generalize the
SKAT and Burden tests in the following forms:
QϕS = S
ϕ>W 2Sϕ =
p∑
j=1
w2j
(
n∑
i=1
φϕi X
∗
ij
)2
, (4)
QϕB = S
ϕ>W1p1>pWS
ϕ =
(
p∑
j=1
wj
n∑
i=1
φϕi X
∗
ij
)2
, (5)
where W = diag(w1, ..., wp) is the diagonal weight matrix for p individual genetic
variants. Same as in the SKAT and Burden tests, wj’s are pre-determined, and
measures the likelihoods of the jth genetic variant to be functional. Throughout
the paper, we define pj as the sample MAF of the jth variant, and adopt a widely
used weighting scheme in sequence-based association tests (Wu et al., 2011; Ionita-
Laza et al., 2013; Madsen and Browning, 2009). We chose wj = Beta(pˆj, 1, 25) for
rare variants, and wj = Beta(pˆj, 0.5, 0.5) for common variants, where Beta stands
for the density function of a Beta-distribution. The test statistics QϕS and Q
ϕ
B are
in the category of rank-score test, but are distinct from the existing rank score tests
in quantile regression (Koenker et al., 2010). Due to the existence of rare variance,
the co-variance matrix of S is nearly singular. Hence the classical rank-score test in
(Koenker et al., 2010; Gutenbrunner et al., 1993) and its multivariate version in Song
et al. (2017) cannot be applied directly. In section 3, we establish the asymptotic
distributions of QϕS and Q
ϕ
B under the null and alternative hypothesis.
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2.3 Implementation details of iQRAT for sequencing data
In this section, we discuss the practical consideration of implementing the proposed iQRAT
in a sequencing data, which includes (1) the stratification of common and rare variants,
and (2) the combination of test statistics based on different weighting schemes.
Variants Stratification Most gene-level association tests for sequencing data, such as
the SKAT and Burden tests, use weighting schemes that are inversely proportional to
MAF to up-weight the contributions of rare variants and down-weight the contributions
of common variants. As a result, they focus on genetic effects of rare variants. However,
for many complex traits, associated variants may range from rare to common (Li and
Leal, 2008). Such single weighting scheme could undermine the gene-level associations(Wu
et al., 2011; Lee et al., 2012; Jeng et al., 2016; Bomba et al., 2017). For this reason, several
approaches have been proposed (Li and Leal, 2008; Ionita-Laza et al., 2013) to determine
the joint effects of common and rare variants in a gene/region, resulting in improved power
for identifying gene-level associations. In our implementation, we use an adaptive threshold
1/
√
2n as proposed in Ionita-Laza et al. (2013) to stratify the variants into rare and common
groups, where n is the total sample size. This cutoff is simple and practical, as it only relies
on the sample size. Other thresholds can also be used whenever suitable.
We decompose the genetic profile X = (X1,X2), where X1 is the matrix of com-
mon genetic variants whose MAF > 1/
√
2n, and X2 corresponds to rare variants whose
MAF ≤ 1/√2n. Without loss of generality, we orthogonalize the genetic profiles X1
and X2 by projecting X2 onto the sample linear space of X1, and define X˜2 = (I −
Xn1(X
>
n1Xn1)
−1X>n1)X2, where Xn1 is the design matrix associated with X1’s. With this
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transformation, we can rewrite the Model (2) as
QY (τ |C,X) = Cα(τ) + X1β1(τ) + X˜2β˜2(τ).
The two models are equivalent. However, since X˜2 is orthogonal of X1, their estimated
coefficients β̂1(τ) and
̂˜
β2(τ) are asymptotically independent of each other. Such property
makes it easy to combine the test statistics associated with common and rare variants.
Signal Combinations Once we partition the genetic variants into common and rare,
we apply the proposed iQRAT tests on the common genetic variants using all the three
score functions ϕ(τ) respectively; and apply the proposed iQRAT tests on the rare ge-
netic variants using the Normal and Wilcoxon functions only. The Lehmann score assigns
heavy weights at extreme upper quantiles. However, for rare genetic variants, we do not
have sufficient data to assess extreme quantiles. Hence, the Lehmann score is inappro-
priate for rare variants and can lead to variance inflation. As we discussed previously,
each score function captures different aspects of genetic associations. (i.e. the Wilcoxon
score estimates the overall mean effect; the Normal score assigns heavier weights at the
two tails, and hence more powerful in identifying the heteroscedastic effect; and Lehmann
score identifies the tail differences at upper quantiles.) Since the actual genetic associa-
tions are complex and unknown, we propose to combine the p-values from the three scores.
There are several existing approaches in literature to combine multiple p-values, such as
the Fisher’s method, minimum p-value, higher criticism, Berk-Jones (Fisher, 1992; Dudoit
et al., 2003; Jin, 2006; Moscovich et al., 2016; Sun et al., 2019). In our approach, the
p-values from the same set of variants but different score functions ϕ(τ) are highly corre-
lated. These traditional approaches combining p-values require resampling or permutation
to estimate the correlations, which are computationally undesirables. Hence, we use the
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Cauchy combination test recently proposed in Liu and Xie (2018) that is computationally
simple and avoids the numerical estimation of correlations. Let p1, ..., pk be k p-values,
which follow a uniform (0,1) distribution under the null hypothesis. Cauchy combination
combines them by
∑k
i=1 tan{(0.5 − pi)pi}/k. One can show that tan{(0.5 − pi)pi} follows
a standard Cauchy distribution for any i. Following this feature of the standard Cauchy
distribution,
∑k
i=1 tan{(0.5− pi)pi}/k is also a standard Cauchy distribution for any k. In
other words, the test correlations have limited effect on the tail distribution of Cauchy
combined p-values, and we easily use the standard Cauchy distribution to determine the
overall p-value of the combined statistics.
After the Cauchy combination, we have one p-value from the common genetic variants,
and one p-value from the rare genetic variants. Due to orthogonalization, and two p-
values are asymptotically independent, and hence can be combined using Fisher’s method.
Fisher’s method is based on the fact that −2∑Kk log pk ∼ χ22K , where pk are individually
independent p-values, and K is the number of p-values to be combined. The overall gene-
level associations is then determined by Fisher combined p-values.
3 Asymptotic results
3.1 Asymptotic distributions for QB and QS
In this section, we establish the asymptotic distributions for the test statistics QϕS and
QϕB respectively under the null hypothesis and a set of local alternatives. We outline
the conditions under which we derived the asymptotic distributions of the proposed test
statistics in Supplementary Material.
The two iQRAT test statistics QϕS and Q
ϕ
B, as defined in eq(4)-(5), are built upon
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the rank-score statistics Sϕ = n−1/2
∑n
i=1 X
∗>
i φ̂
ϕ. When X is univariate, Koenker et al.
(2010) has shown that, with the outlined conditions in the Supplementary Material, the
statistics Sϕ is asymptotically normally distributed. Following the asymptotic normality
of Sϕ, we derive the asymptotic distributions of QϕS and Q
ϕ
B. For simplicity, we define
Σ = n−1X∗>X∗, explaining the component that does not depend on ϕ(·) and the error
distribution.
Under the null hypothesis:
Theorem 1. Under the conditions A-C, and under the null hypothesis H0 : β(τ) = 0, we
have
1. Sϕ is asymptotically normal distributed Sϕ = AN(0, σ2ϕΣ), where σ
2
ϕ =
∫
(ϕ(t)− ϕ¯)2dt
and ϕ¯ =
∫ 1
0
ϕ(t)dt.
2. QϕS is asymptotically a mixture χ
2
1 distribution: Q
ϕ
S = σ
2
ϕ
∑p
j λjχ
2
1, where λj, j =
1, ...,m are positive eigenvalues of Σ1/2W 2Σ1/2; If Σ1/2W 2Σ1/2 is semi-positive defi-
nite, we sum over the first m positive eigenvalues instead of all p eigenvalues.
3. QϕB follows a scaled χ
2
1 distribution: QB = σ
2
ϕλχ
2
1, where λ = 1
>
pWΣW1p.
The rank-score statistics Sϕ is distribution-free in the sense that its asymptotic distri-
bution under the null hypothesis only depends on the score/weight function ϕ(t) and the
design matrix. This feature makes it flexible to accommodate a wide range of distributions.
Under the alternative hypothesis: When β(τ) 6= 0, the test statistics QϕS and QϕB are
no longer mean zero. Their non-central parameters η depend on the form of alternatives
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β(τ), error distribution F and the weight score function ϕ(τ). Theorem 2 presents the
asymptotic distributions of QϕS and Q
ϕ
B under alternatives.
Theorem 2. Under the conditions A-C, we have
1. Sϕ is asymptotically normal distributed: Sϕ = AN(ξ>Σ, σ2ϕΣ)., where ξ = (ξ1, ..., ξp),
and ξj =
∫ 1
0
f(F−1(τ))βj(τ)dϕ(τ) for j = 1, ..., p;
2. The distribution of QϕS converges to a linear combination of non-central chi-square dis-
tributions QϕS
d−→∑mj σ2ϕλjχ21(ηj), where λj’s are the positive eigenvalues of Σ1/2W 2Σ1/2
and ηj’s are non-central parameters. Let U is an orthonormal matrix which satisfies
Λ = UΣ1/2W 2Σ1/2U> and Λp×p = diag(λ1, ..., λm, 0, ..., 0). We can write the non-
central parameters ηj = µ
2
j where µj is the j
th element of µ = UΣ−1/2ξ/σϕ.
3. The distribution of QϕB converges to a scaled non-central chi-square distribution QB =
λχ21(η), where η = ξ
>ΣW1p1>pWΣξ and λ = σ
2
ϕ1
>
pWΣW1p.
Proofs for Theorem 1-2 can be found in Supplementary Material.
In theory, one can choose an optimal ϕ(τ) by maximizing the non-central parameter.
However, the non-central parameters depend on actual β(τ) and F , which are often un-
known and could be very different across genes. Hence, it is hard to identify a simple ϕ(τ)
that works for all genes. Adaptive ϕ(τ) is appealing but often numerically challenging.
Hence combining multiple pre-determined but representative ϕ is a more practical strategy
to accommodate complex associations and to enhance the statistical power.
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3.2 Asymptotic efficiency of the iQRAT tests
In this section, we compare the asymptotic efficiency of the proposed iQRAT tests with
their mean-based counterparts, SKAT and Burden tests, under local alternative settings.
To this end, we define R2(T ) = µ2(T )/Var(T ) as the efficiency measure of a test statistics T ,
where µ(T ) and Var(T ) are its asymptotic mean and variance. Without loss of generosity,
we assume that X is uni-variate with variance 1. The same results hold for multiple
dimensional X. In this uni-variate setting, QϕS and Q
ϕ
B are equivalent, and QSKAT and
QBurden are also equivalent as well. In the rest of the discussions, we only compare Q
ϕ
S with
QSKAT.
As we derived in Theorem 2, the asymptotic distribution of QϕS is the same as the
distribution of σ2ϕ
∑
j λjχ
2
1(ηj), where χ
2
1(ηj)’s are independent non-central chi-square dis-
tributions with non-central parameters ηj and degree-of-freedom 1. The non-central pa-
rameters ηj = ξ
>u>j ujξ/(σ
2
ϕλj), where λj and uj only depend on X, σ
2
ϕ =
∫
(ϕ(t)− ϕ¯)2dt,
ϕ¯ =
∫ 1
0
ϕ(t)dt, ξ = (ξ1, ..., ξp) and ξj =
∫ 1
0
f(F−1(τ))βj(τ)dϕ(τ) for j = 1, ..., p. On the
other hand, the asymptotic distribution of QSKAT shares the same form, except that ξ is
replaced by β = (β1, ..., βp) and βj =
∫ 1
0
βj(τ)dτ for j = 1, ..., p, and σ
2
ϕ is replaced by
σ2 = β
2
σ2x + σ
2
e = β
2
+ σ2e . It follows that we can write R
2(QϕS) and R
2(QSKAT) by
R2(QϕS) =
(1 + ξ2/σ2ϕ)
2
2(1 + 2ξ2/σ2ϕ)
and R2(QSKAT) =
(1 + β¯2/σ2)2
2(1 + 2β¯2/σ2)
.
The efficiency depends on the alternative hypothesis β(τ), the error distribution F and the
weight score function ϕ(τ). Since normalization is a common practice in genetic association
tests, we consider F as a standard normal distribution in this section. Empirical power
comparisons with non-normal distributions can be found in the later section of simulations.
We consider two local alternative hypotheses. The first one is Hn : β(τ) = n
−1/2β0, ∀τ ∈
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Figure 1: Compare R2 for different test statistics under the location (Left) and Lehmann
(Right) alternatives. R2(ϕ1), R
2(ϕ2), R
2(ϕ3) represent R
2 for QϕS based on Wilcoxon (ϕ1),
Normal (ϕ2) and Lehmann (ϕ3), respectively.
(0, 1). Under this alternative, the quantile effect is homogeneous across all quantile levels,
and hence works in favor of the mean-based tests. It follows that β = β0 and ξ = β0γ(ϕ, F ),
where γ(ϕ, F ) =
∫ 1
0
f(F−1(t))dϕ(t). When F is standard normal, γ(ϕ1, F ) = (2
√
pi)−1 =
0.282, γ(ϕ2, F ) = 1 and γ(ϕ3, F ) ≈ 0.903. We plot the R2(QϕS) and R2(QSKAT) as the
function of β0 in Figure 1. It shows that Q
ϕ
S has better asymptotic efficiency than QSKAT,
and the advantage increases with β0. Among the three score functions, the Normal score
(ϕ2) has slightly better efficiency than the other two. This observation is consist with
Gutenbrunner et al. (1993); Koenker et al. (2010).
We also considered another local alternative with heterogeneous quantile effect. Let
H(x) be the distribution of Y without mutation (X=0), and G(x) be that with mutation
(X = 1). The quantile effect β(τ) = G−1n (τ) −H−1(τ). We consider the local alternative
Hn : β(τ) = γ0(f(F
−1(τ)))−1[−(1 − τ) log(1 − τ)]/√n + o(1/√n) for a constant γ0. It is
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equivalent to Hn : G(x) = H(x)
1+γ0/
√
n. Under this local alternative, the quantile effect
β(τ) increases with the quantile level τ , and across-quantile heterogeneity increases with
γ0. We derived ξ and β under this setting, and plot the R
2(QϕS) and R
2(QSKAT ) as the
function of γ0 in Figure 1. We observed the efficiency gain of iQRAT over SKAT that
increases with γ0. Among the three score functions, R
2(Qϕ3S ) is better than R
2(Qϕ1S ) and
R2(Qϕ2S ), which is expected since ϕ3 is designed to maximize the non-central parameter ξ
under Lehmann alternatives Koenker et al. (2010).
3.3 Computational Approximation for p-values
Following Theorem 1 in the previous section, the test statistics QϕB follows a scaled Chi-
square distribution under the null, and hence one can readily derive the critical values as
well as the p-values. The asymptotic distribution of QϕS, however, follows a weighted sum
of Chi-square distributions. Analytically deriving the critical values of such distribution is
hard. In this section, we outline a numerical approximation to calculate the critical values
and the p-values of QϕS.
The approximation extends from Liu et al. (2009) and Lee et al. (2012). The basic
idea is to find a non-central Chi-square distribution χ2ξ(γ) with non-centrality parameter
γ and degree of freedom ξ, such that its selected moments including mean, variance, and
kurtosis match with those of QϕS. For simplicity, we denote Q
ϕ
S as QS in this section.
Let ck =
∑p
j=1 λ
k
j , s1 = c3/c
3/2
2 and s2 = c4/c
2
2. Then, the mean, standard deviation,
skewness and kurtosis of QS can be written as µQS = c1, σQS =
√
2c2, skewQS =
√
8s1,
kurtQS = 12s2. We then determine ξ and γ by matching the skewnesses of QS and χ
2
ξ(γ)
while minimizing the kurtosis of QS and χ
2
ξ(γ). Consequently, if s
2
1 > s2, we choose
γ = s1a
3 − a2 and ξ = a2 − 2γ, where a =
(
s1 −
√
s21 − s2
)−1
; and if s21 < s2, we choose
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γ = 0 and ξ = 1/s22. Finally, we approximate the tail probability Pr(QS > t) for any t by:
Pr(QS > t) = Pr
(
QS − µQS
σQS
> t∗
)
≈ Pr
(
χ2ξ(γ)− µχ
σχ
> t∗
)
= Pr
(
χ2ξ(γ) > t
∗σχ + µχ
)
,
where t∗ = (t − µQS)/σQS , µχ = E(χ2ξ(γ)) = ξ + γ, σ2χ = 2(ξ + 2γ). When sample size is
small, one can use a small-sample adjustment proposed in Lee et al. (2012) to calculate the
eigenvalues of Σϕ to better approximate the tail effect. Other numerical approximations
including Davies’ method (Davies, 1987) produce fairly similar results.
4 Simulation
4.1 Simulation Models and Settings
In this section, we present a simulation study to demonstrate the finite sample performance
of the proposed test under various genetic models and various distributions of the pheno-
type. Throughout the numerical investigations, we compare the proposed iQRAT statistics
(QS and QB) to the traditional mean-based tests. Specifically, we compare the proposed
QS to the SKAT-C and SKAT-A tests proposed in Ionita-Laza et al. (2013). Both first
apply the SKAT test to rare and common variants separately; SKAT-C then combines
them with equal weights, while SKAT-A combines them with adaptive weights for a better
power. Likewise, we compare the proposed QB to corresponding Burden tests, the Burden-
C and Burden-A tests in Ionita-Laza et al. (2013). These SKAT and Burden tests were
implemented via the function SKAT CommonRare in the R package SKAT (Lee et al., 2017).
In what follows, we describe the numerical procedure to generate a random sample
(yi,Xi,Ci), i = 1, ..., n, that mimics a sequencing data. We first use the simulated haplo-
type dataset from SKAT package to generate individual genotype profiles Xi. The reference
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data set consists of 10,000 haplotypes over 200kb region, including 3,845 SNPs. These
haplotypes were simulated using a calibrated coalescent model (COSI, (Schaffner et al.,
2005)), mimicking linkage disequilibrium structure of European ancestry. For each simu-
lated data, we randomly select a roughly 3.5kb region from the reference data, and treat
it as the “targeted” gene. We then generate individual genetic profiles Xi in that “gene”
by randomly drawing and combining two haplotype sequences from the 10,000 haplotypes.
Moreover, we calculate sample MAF of all the SNPs in each selected region/gene from the
reference data, and randomly picked 20% common variants and 30% rare variants as causal
variants. Finally, we consider the following quantile models to generating the phenotype
Yi. In all the models, we assume the covariate Ci ≈ N(4, 1), and respectively consider four
error distributions, namely N(0, 1), χ22, Cauchy(0, 1), and t2.
Model 1: a location model. We assume that the phenotype Yi follows the model
Yi = 1 + 1.2Ci + Xiβ + ei
where Xi is the genoytpe of the i-th observation on the k causal SNPs, β = (β1, .., βj, ...βk),
βj = β| log10(mj)| and mj represents the sample MAF of the jth causal variant. We
let β = 0.3 when the error distribution of ei is N(0, 1) or χ
2
2, and let β = 0.6 when
the error distributions are Cauchy(0, 1) or t2 with heavy tails and larger variation.
Model 2: a location-scale model. We simulated phenotype Yi from the following model,
Yi = 1 + 1.2Ci + Xiβ + (1 + Xiγ)ei, i = 1, ..., n, (6)
where βj = β| log10(mj)|, γj = γ| log10(mj)|. We let γ = 0.1, β = 0.3 when error
distribution is N(0, 1) or χ22; and let γ = 0.2, β = 0.6 when error distribution is
Cauchy(0, 1) or t2.
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Model 3: a location-scale model with bi-directional associations. Same model as
in Model 2, but we randomly select 50% of causal variants to have negative effects,
while the others remain positive.
Model 4: local quantile effect models. In this setting, we assume the conditional quan-
tile function of the phenotype Y can be written as
QY (τ |C,X) = 1 + 1.2C + Xβ(τ) + F−1(τ),
where β(τ) = 5β(τ − 0.7)/(1− 0.7) when τ > 0.7 and β(τ) = 0 otherwise. Here the
quantile effects only exist on upper quantiles, i.e., τ ∈ [0.7, 1]. Since the association
only exists in a small interval, we set β = 0.6 when error distribution is N(0, 1), β =
1.2 when error distribution is χ22, and β = 1.8 when error distribution is Cauchy(0, 1)
or t2. To simulate Yi from this model, we use the inverse quantile approach, where
we randomly draw a U(0, 1) random variable as τ , and plug it into the conditional
quantile function QY (τ |Ci,Xi).
After simulating Yi from the models aforementioned, we use the quantile and rank nor-
malization in Qiu et al. (2013) to transform Yi’s into a normal distribution. Since quantile
function is invariant to monotone transformations, the proposed iQRAT actually produces
identical results with and without normalization. We implement the normalization for a
fair comparison with the existing approaches. Otherwise, the existing methods will have
type I error inflation issue especially with non-gaussian errors.
4.2 Type I Error
We first investigate whether the proposed iQRAT (QS and QB) tests preserve the desired
type I error rate at significance levels α = 5e-02, 1e-02, 1e-03, 1e-04, 1e-05, and at the
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exome-wide significance level 2.5e-06. To do so, we simulated the data with sample size
n = 1, 000 under the null model, where β = γ = 0 and ei ∼ N(0, 1) in Model (6). We
present in Table 1 the resulting the type I error from 107 Monte-Carlo replicates. As
shown in Table 1, the iQRAT QB has well-controlled type I errors at all significance levels.
The type I errors of QS are also well controlled except slight inflation at the exome-wide
significance level 2.5e-06. SKAT-A also has inflated type I errors at the 1e-05, and at the
exome-wide significance level. Similar results were found in other scenarios where the error
terms e follow non-Gaussian distributions and where the data have different sample sizes
(presented in Supplementary Material Table 2).
α = 5e-02 α = 1e-02 α = 1e-03 α = 1e-04 α = 1e-05 α = 2.5e-06
SKAT-C 4.9e-02 9.6e-03 9.3e-04 9.2e-05 1.1e-05 2.5e-06
SKAT-A 4.7e-02 9.3e-03 9.9e-04 1.1e-04 1.4e-05 4.3e-06
QS 4.8e-02 9.3e-03 9.4e-04 9.9e-05 1.1e-05 3.5e-06
Burden-C 5.0e-02 9.9e-03 9.6e-04 9.6e-05 9.6e-06 2.4e-06
Burden-A 5.0e-02 1.0e-02 1.0e-03 1.1e-04 1.0e-05 2.1e-06
QB 5.1e-02 1.0e-02 9.9e-04 9.8e-05 8.7e-06 1.3e-06
Table 1: Comparison of Type I errors with Normal error distributions..
4.3 Power
Following the assessment of Type I errors, we investigate and compare the empirical powers
of the proposed iQRAT tests, the SKAT and Burden tests under the outlined model settings
in Section 4.1. We simulate data from each model setting with 4 four different sample sizes
n = 100, 500, 1000, 2000. We applied the proposed iQRAT tests, as well as the SKAT
and Burden tests, to detect gene-level associations at the genome-wide significance level
α = 2.5e-6. We calculate the empirical powers with 105 Monte-Carlo replicates. We present
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Figure 2: Power summary in Model 1 (location shift) at significance level α =2.5e-06.
in Figure 2 the resulting power curves (as the functions of sample size) under the Model 1
(i.e., the location model) with each sub-figure representing one specific error distribution.
The results of the Model 2 (i.e., the location-scale model), Models 3 (location-scale model
with bidirectional associations) and Model 4 (the local quantile effect model) are included in
the Supplementary Material Figure 1 - 3 to keep the main text concise. In all the plots, we
use solid lines for dispersion tests, including SKAT-A, SKAT-C, and the proposed QS, and
use dotted lines for Burden tests, including the Burden-A, Burden-C and the proposed QB.
We also use circles for SKAT-C and Burden-C, use triangles for SKAT-A and Burden-A
and use plus signs for the proposed QS and QB tests.
Under the location model (Model 1), when the phenotype follows a normal distribution,
the proposed iQRAT tests are as powerful as the mean-based SKAT and Burden tests.
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When the error distributions deviate from the normal distribution and present skewness
and heavier tails, the proposed iQRAT is more powerful than both SKAT and Burden
tests. The efficiency gains are more evident as the sample size increase. We observed
even higher efficiency gain of the proposed iQRAT tests when the associations are more
complicated that the genetic effects on the phenotype are beyond a location shift (Models
2-4). In all the analyses, we normalized the response Y to follow the standard practice
in genetic association tests. Such normalization only ensures the marginal distribution of
Y is approximately normal, but not the conditional distributions of Y given X and C.
In reality, it is unlikely that all the conditional distributions of Y given X and C are
normally distributed. For this reason, we observed improved power with non-normal error
distributions.
We have also conducted simulations to investigate how the power of the proposed tests
changes with causal rates, see Supplementary Material. To examine the impact of the
causal rate on the testing power, we reduced the nominal causal rate to be 10% common
and 10% rare in each region, and simulated the data from Model 2 with the sample size
1000. The results are presented in the Supplementary Material Figure 4, including the
causal rate we used in the previous settings (30% rare and 20% common), and the new
lower causal rate (10% rare and 10% common). In both cases, the proposed test statistics
are more powerful in all scenarios than their mean-based competitors.
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5 Metabochip Data Analysis for Lipid Traits
5.1 Data Description
In this section, we implemented the proposed tests to the Metabochip dataset. The
Metabochip is a custom genotyping array that assays nearly 200,000 variants in order to
assess associations with traits such as type 2 diabetes, fasting glucose, coronary artery dis-
ease and myocardial infarction, low density lipoprotein cholesterol, high density lipoprotein
cholesterol, triglycerides, body mass index, systolic and diastolic blood pressure, QT inter-
val, and waist-to-hip ratio adjusted for BMI, etc (Voight et al., 2012). More specifically, we
applied the proposed iQRAT on a Metabochip dataset on lipid phenotypes focusing on 265
genes in 99 gold fine-mapping regions. The four lipid traits we considered are low-density
lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol
(CHOL) and triglycerides (TG). The dataset we used contains data on 12,281 individuals
from eight studies include Finnish: FUSION stage 2 (n = 2, 741), D2D 2007 (n = 2, 108),
DPS (n = 429), METSIM (n = 1, 439), DR’s EXTRA (n = 1, 242); Norwegian: HUNT,
Tromsø(n = 2, 793 together); German: DIAGEN (n = 1, 529). The two Norwegian cohorts
are analyzed jointly as in He et al. (2018). As a result, we have seven independent sites for
the subsequent meta-analysis. In the reported sample sizes, we have excluded samples and
SNPs with call rates < 98%, and also excluded any incomplete data with missing outcomes
or covariates. The missing values in genotypes were imputed using mean imputation.
In all the tests, we have adjusted for the covariates gender, age, squared age, and type
2 diabetes status for each study. For METSIM, we did not adjust for gender because it
contains males only. For the two Norwegian studies, we additionally adjusted for study
region. We did not adjust for principal components accounting for ancestry, because the
25
Metabochip data is targeted array rather than genome-wide. The adjustments mentioned
above are consistent with Lee et al. (2013) and He et al. (2017).
5.2 Meta-analysis Results
We first respectively apply all the tests under comparison to each study site, and then use
Fisher’s method (Fisher, 1992) to combine the p-values cross the seven sites. Specifically,
let p` be the p-value of a given test on a given gene in the `-th study, for ` = 1, ..., 7. We
combine p`’s by −2
∑7
`=1 log(p`), which follows χ
2
14 under the null hypothesis. Same as in
the simulation study, we have compared to the existing tests, including SKAT-C/SKAT-A
and Burden-C/Burden-A.
For each testing method, once we obtained Fisher-combined p-values for all the genes, we
used the Benjamini-Hochberg (B-H) procedure proposed in Benjamini and Hochberg (1995)
to determine the p-value thresholds for controlling the False Discovery Rate (FDR) < 0.05.
We described step-by-step in Supplementary Material the implemented B-H procedure,
and the resulting thresholds for each test and each trait (Supplementary Material Table
3). In Supplementary Material Table 4, we list all the genes (grouped by traits) that
were identified by at least one of the six testing methods after their FDR adjustment.
Similar to what we found in the simulation studies, the dispersion-based tests, including
SKAT-A/C and iQRAT QS, identify more genes than the Burden-type tests. Among the
identified associations, several of them are well-known in the literature, such as CETP for
HDL , PCSK9 and LDLR for LDL , LPL for TG, etc (He et al., 2018). Other identified
associations were also reported in related literature (see Supplementary Material Table 5).
Efficiency-wise, iQRAT tests identified all the significant genes that are detected either
by its competitors, with only one exception, gene PCSK9 with the trait CHOL, where
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Figure 3: Quantile signals for APOB-HDL, APOB-CHOL and TDRD15-LDL with the grey
lines indicates 95% confidence interval by bootstrap.
the p-value from iQRAT QS is slightly lower than that of SKAT-C. In the meantime, two
gene-level associations, APOB with HDL and APOB with CHOL, were only identified by
iQRAT QS, and one gene-level association, TDRD15 with LDL, was only identified by QB.
The associations of APOB with HDL and CHOL are confirmed in Niu et al. (2017), whereas
TDRD15 is related to the LDL associated disease – coronary artery disease (Paquette et al.,
2017). The results are consistent with the theoretical findings on the potential efficiency
gain of the iQRAT test and are also consistent with the simulation studies.
To obtain empirical evidence and also an in-depth understanding on gene-trait associ-
ations, we propose to visually examine the quantile effects. To do so, we partition each
target gene by common and rare SNPs. For each subject i, we calculate its mutation
burden among common SNPs by BScorei,common =
∑
j∈Γ1 sign(βˆj)wjXij with , where Xij
is his genotype on the j-th SNP, Γ1 is the index set for common variants, sign(βˆj) in-
dicates the direction of the association between the j-th variant and the trait estimated
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from a linear model, and wj is the weight on the jth variant in the proposed test statis-
tics. Following the same fashion, we calculate the mutation burden among rare SNPs,
BScorei,rare =
∑
j∈Γ2 sign(βˆj)wjXij, where Γ2 is the index set for rare variants. If a sub-
ject’s mutation burden exceeds the sample median, either among the common variants or
among the rare variants, we assign the subject into the ”high mutation” group. The rest
of the subjects constitute the ”reference” group. We then calculate the empirical quantile
functions of the two groups, plot their difference over quantile levels, and construct its 95%
confidence band by within-group bootstrapping. We apply this procedure to APOB-HDL,
APOB-CHOL, and TDRD15-LDL, the three gene-trait associations that were only identi-
fied by iQRATs. We present the results in Figure 3, based on which we observe significant
quantile effects that support the genetic associations of APOB-HDL, APOB-CHOL, and
TDRD15-LDL. For APOB-HDL and APOB-CHOL associations, the effects are stronger at
upper quantiles than lower quantiles, which suggest APOB has a lightly stronger impact
among subjects with high HDL and CHOL levels. The TDRD15-LDL association are close
to zero at quantile levels lower than 0.2, but is consistently strong for higher quantile levels.
The existing of quantile effect changing point suggest a mixture structure of TDRD15-LDL
association.
6 Discussion
In this paper, we propose an efficient integrated quantile test (iQRAT) based on weighted
rank scores processes. Compared to the widely-used mean-based dispersion and Burden
tests, our method has the following advantages. (1) It is efficient and distribution-free. By
design, it is as efficient as the mean-based dispersion and Burden tests for homogeneous
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associations, and is more efficient in the presence of heterogeneous associations. Since
the test statistics and its asymptotic distributions under the null are distribution-free, it
is widely applicable to accommodates complex and heterogeneous associations. (2) Since
quantile association is invariant to monotone transformation, it simplifies the data pro-
cessing procedure by avoiding normalization, and enables direct interpretation on how a
gene associates with the distribution/quantile functions of the phenotype. Such insights
are especially useful for exploring the genetic architecture of complex traits in more details.
Moreover, avoiding normalization also facilitates meta-analyses, which is commonly per-
formed in genetic analyses of multiple studies. Since the transformation functions used in
normalization vary across individual studies, the summary statistics under different normal-
ization are not completely comparable from a technical perspective, which raises concerns
when combining them across different studies. Since iQRAT is invariant to normalization,
combining iQRAT test statistics across multiple studies is straightforward.
Although the proposed iQRAT test requires the estimation of the entire conditional
quantile process, it is computationally feasible for large scale sequencing data due to the
following reasons. (1) The estimation of quantile process uses the parametric linear pro-
gramming technique that is much faster than estimating individual quantile functions. (2)
The use of Cauchy combination to combine different weighting schemes is computation-
ally simple. In the Metabochip data that we analyzed, iQRAT can be fully implemented
within 1 second for testing a single gene in any of the eight studies, see the Supplementary
Material for a summary of computational time.
In the proposed iQRAT, we considered and combined three weighting score functions,
each of them representing a different type of association. The Wilcoxon weight combines
quantile effects equally across quantile levels, and is equivalent to testing the mean-level
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association. The Normal weight is heavier at the two tails and lighter in the middle range,
and hence is more sensitive to the effects on variance. The Lehman weight, on the con-
trary, assigns heavy weight at the upper tail, and diminishes as quantile level decreases. It
is designed to detect the right tail differences and location-scale changes. By combining the
various weighting schemes, the proposed iQRAT could support a wider range of complex
and heterogeneous associations. Depending on individual applications, other weighing func-
tion could be used without the changing of asymptotic theories. Instead of pre-determined
weight functions, it is also of interest to consider adaptive weights that may accommodate
more complex associations. One could consider a two-stage procedure which estimate the
quantile specific effect first, and then incorporate it into an integrated test. Implementation
of such more adaptive integrated test with type I error control warrant future research.
In our application to the Metabochip data, most of the significant associations identified
by iQRAT have already been identified using the classical SKAT-C/-A tests. Given that
in general we only expect a small proportion of associations to manifest with higher order
moments of the phenotype distribution, this is expected, since we focused here on a small
number of genes in 99 fine mapping regions. It is therefore of interest to apply the proposed
methods to the genome-wide setting and multiple phenotypes to fully benefit from the
power improvements we have shown in the simulations.
R package
The proposed method has been fully implemented in the R package iQRAT, available on
Github: https://github.com/tianyingw/iQRAT. We will submit the package to CRAN
once the paper is accepted.
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SUPPLEMENTARY MATERIAL:
uppercaseIntegrated Quantile RAnk Test (iQRAT) for gene-level
associations in sequencing studies
1 Technical details for Theorems 1 and 2
We present in this section the sufficient conditions for the Theorems 1 and 2, as well as
their technical proofs. Recall that we model the conditional quantile of phenotype Y given
gene X and covariates C by
QY (τ |C,X) = α0(τ) + Cα1(τ) + Xβ(τ),
where α0(τ) is the intercept function. Under this model, Y |(C,X) has the same distribution
as α0(U) + Cα1(U) + Xβ(U), where U is a random variable following a uniform (0, 1)
distribution. Hence, we can view α0(U) as the random error, whose distribution function
F (·) is the inverse function of α0(τ). We first outline the conditions on F (·) and its derived
density function f .
Condition A:
(A.1) |F−1(α)| ≤ c(α(1 − α))−a for 0 < α ≤ α0, 1 − α0 ≤ α < 1, where 0 < a ≤ 1/4 − ,
 > 0 and c > 0
(A.2) 1/f(F−1(α)) ≤ c(α(1− α))−1−a for 0 < α ≤ α0 and 1− α0 ≤ α < 1, c > 0.
(A.3) The density function f(x) > 0 is absolutely continuous,positive for A < x < B, and
monotonically decreasing as x → A+ and x → B−, where −∞ ≤ A ≡ sup{x :
F (x) = 0} and +∞ ≥ B ≡ inf{x : F(x) = 1}. The derivative f ′ is bounded a.e.
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(A.4) | f ′(x)
f(x)
|≤ c|x| for |x| ≥ K ≥ 0, c > 0
Similar conditions on f and F can be found in Gutenbrunner et al. (1993); Gutenbrunner
and Jureckova´ (1992).
Denote Zn = (1n,Cn,Xn) be the entire design matrix, the following conditions need to
be satisfied in order to obtain a valid Bahadur representation of the test statistics.
Condition B:
(B.1) limn→∞Dn = D where Dn = n−1Z>nZn and D is positive definite.
(B.2) n−1
∑n
i=1 ‖zi‖4 = O(1) as n→∞.
(B.3) max1≤i≤n‖zi‖ = O(n(2(b−a)−δ)/(1+4b)) for some b > 0 and δ > 0 such that 0 < b− a <
/2 (hence 0 < b < 1/4− /2)
Finally, we outline the conditions on the weighting function ϕ(t).
Condition C: Let ϕ(t) : 0 < t < 1 be a nondecreasing square integrable function. The
derivative ϕ′(t) exists for t ∈ (0, α0)∪ (1− α0, 1), and satisfies |ϕ′(t)| ≤ c(t(1− t))−1−δ∗ for
some δ∗ < δ, where δ is defined above in the condition (B.3).
The three functions we considered in our approach satisfy these conditions.
Lemma 1. (Properties of the regression rank scores process) Define
W dn = {W dn(t) =
√
n
n∑
i=1
dniaˆni(t) : 0 ≤ t ≤ 1}, (7)
where {dni : i = 1, ..., n} is a standardized triangular array from Rp. Assume the
errors e1, ..., en are independent and identically distributed with distribution function F (x).
Gutenbrunner et al. (1993) showed
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1. the process W dn(t) = U
d
n(t) + op(1) as n→∞ uniformly on any fixed interval [, 1− ]
with 0 <  < 1/2, where
Udn(t) = n
−1/2
n∑
i=1
dniI[ei > F
−1(t)].
2. W dn converge weakly to the Brownian bridge over the interval [, 1− ].
For the rank scores with non-constant in the tails, Gutenbrunner et al. (1993) studied
their asymptotic behavior of the rank score ϕ and the test statistic Sn, extended the weakly
convergence of eq(7) to the Brownian bridge at the tails of [0, 1].
Lemma 2. (Gutenbrunner et al., 1993, Theorem 3.3) Let dn = (dn1, ..., dnn)be a sequence
of vectors satisfying:
(D.1) Z>n dn = 0, n
−1∑n
i=1 d
2
ni → ∆2, 0 < ∆2 <∞
(D.2) n−1
∑n
i=1 |dni|3 = O(1) as n→∞
(D.3) max1≤i≤n |dni| = O
(
n(2(b−a)−δ)/(1+4b)
)
.
Zn and F satisfy conditions (X.1)-(X.3) and (F.1)-(F.4) listed in Gutenbrunner et al.
(1993) respectively. Then, as n→∞,
sup
0≤α≤1
{|n−1/2
n∑
i=1
dni(aˆni(α)− α˜ni(α))|} p−→ 0,
where a˜i(α) = I[ei ≥ F−1(α)], i = 1, ..., n. Further, the process {∆−1n−1/2
∑n
i=1 dniaˆni(α) :
0 ≤ α ≤ 1} converges to the Brownian bridge in the Prokhorov topology on C[0, 1].
Lemma 3. (Asymptotic normality of Sn) According to Theorem 4.1 in Gutenbrunner et al.
(1993), ϕ(t) : 0 < t < 1 should be a non-decreasing square integrable function and satisfy a
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condition of the Chernoff-Savage (Chernoff and Savage, 1958) type. Then, with scores bˆni,
the simple linear regression rank-score statistic Sn = n
−1/2∑n
i=1 dnibˆni has an asymptotic
representation as
Sn = n
−1/2
n∑
i=1
dniϕ(F (ei)) + op(1),
and is asymptotically normal distributed with zero expectation and with variance
∆2(
∫ 1
0
ϕ2(t)dt− ϕ¯2), ϕ¯ =
∫ 1
0
ϕ(t)dt.
Proof 1 (Theorem 1 & Theorem 2). We here prove Theorem 1 & 2 together, since their
difference is caused only by the mean of Sϕ under the null and alternative hypothesis.
1. We first show the asymptotic normality of Sϕ. Using Lemma 3, the asymptotic dis-
tribution of Sn under H0 is the same as asymptotic distribution of Sn = n
−1/2X∗>b˜,
where b˜ = {ϕ(F (ei))}ni=1. Then, according to Gutenbrunner et al. (1993), the se-
quence of local alternatives Hn is contiguous with the sequence of H0 with densities
{Πni=1f(ei)}, and the simple rank score statistics defined in Lemma 3 still hold under
local alternatives.
2. Now we show the asymptotic distribution of QϕS under the null model. For simplicity,
we denote QϕS as Qs = S
>W 2S, S = AN(µs,Σs), where Σs is non-negative definite.
Denote U as a orthornormal matrix which satisfies UΣ
1/2
s W 2Σ
1/2
s U> = Λ, where
Λ = diag(λ1, ..., λp). Then H = UΣ
−1/2
s S = N(UΣ
−1/2
s µs, I) Thus, Qs asymptotically
follows
Qs = S
>W 2S = H>ΛH =
p∑
j=1
λjχ
2
aj
(ηj),
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where aj = 1; ηj = (µHj)
2 = (ujΣ
−1/2
s µs)
2; uj is the j
th row of U . If rank(Σs) = m,
Qs =
∑m
j=1 λjχ
2
1(ηj) with λ1,≥ .. ≥ λm > 0.
3. The asymptotic distribution of QϕB can also be derived based on the asymptotic normal-
ity of Sϕ. Since 1>pWS = AN(1
>
pWµs, 1
>
pWΣsW1p), λ
−1/21>pWS = AN(1
>
pWµs, 1),
where λ = 1>pWΣsW1p. Then QB = (λ
−1/21>pWS)
2 ∼ χ21(η), where η = µ>sW1>p 1pWµs.
Finally, plug in the the form of µs and Σs under H0 and Ha respectively, we finish the
proof of Theorem1 and 2.
2 Additional simulation results in Section 4
In this section, we first present in Table 1 the type I errors of the proposed iQRAT tests
(QS and QB) with four different error distributions (i.e. Normal, Chi-square, Cauchy and
t2) and four different sample sizes (n = {100, 500, 1000, 2000}), with the comparison to the
SKAT and Burden tests. We observed that both QS and QB have well-controlled type I
errors across all scenarios. Burden tests (Burden-A and Burden-C) also have desired type
I error with four types of error distributions. SKAT-A test, however, has inflated type I
errors when error distributions are non-normal.
In Figures 1-3, we present the empirical powers of iQRAT, SKAT and Burden tests
under Models 2-4 with various sample sizes. We also compared the empirical power with
different causal ratios, and plotted the resulting power curves in Figure 4. In all these plots,
we observed that the proposed iQRAT outperforms both SKAT and Burden tests across
different sample sizes and causal ratios.
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Figure 1: Power summary in Model 2 (location and scale shift) at significance level α =2.5e-
06.
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Figure 2: Power summary in Model 3 (location scale model with bi-directional associations)
at significance level α =2.5e-06.
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Figure 3: Power summary in Model 4 (local quantile signals) at significance level α =2.5e-
06.
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Figure 4: Power summary in location and scale shift model with different causal rate at
significance level α =2.5e-06.
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SKAT-C SKAT-A QS Burden-C Burden-A QB
n = 100
N(0, 1) 5.0e-05 3.0e-05 2.0e-05 3.0e-05 3.0e-05 2.0e-05
χ22 5.0e-05 1.4e-04 3.0e-05 1.3e-04 1.2e-04 3.0e-05
Cauchy 2.0e-05 4.0e-05 4.0e-05 8.0e-05 1.0e-04 6.0e-05
t2 7.0e-05 2.2e-04 6.0e-05 6.0e-05 8.0e-05 1.0e-04
n = 500
N(0, 1) 9.0e-05 1.1e-04 6.0e-05 8.0e-05 1.2e-04 1.0e-04
χ22 1.5e-04 2.1e-04 1.3e-04 1.1e-04 1.5e-04 7.0e-05
Cauchy 1.2e-04 1.6e-04 1.0e-04 9.0e-05 1.2e-04 1.2e-04
t2 1.0e-04 2.3e-04 1.0e-04 1.3e-04 1.5e-04 1.0e-04
n = 1000
N(0, 1) 1.3e-04 1.4e-04 9.0e-05 9.0e-05 9.0e-05 8.0e-05
χ22 7.0e-05 1.5e-04 9.0e-05 9.0e-05 8.0e-05 1.0e-04
Cauchy 1.1e-04 1.3e-04 6.0e-05 5.0e-05 4.0e-05 9.0e-05
t2 7.0e-05 1.2e-04 9.0e-05 1.3e-04 1.6e-04 1.3e-04
n = 2000
N(0, 1) 6.0e-05 1.2e-04 8.0e-05 9.0e-05 1.1e-04 9.0e-05
χ22 4.0e-05 1.3e-04 1.1e-04 1.3e-04 1.7e-04 1.3e-04
Cauchy 1.0e-04 1.0e-04 8.0e-05 8.0e-05 7.0e-05 3.0e-05
t2 1.2e-04 1.7e-04 1.2e-04 1.4e-04 1.1e-04 8.0e-05
Table 1: Summary for type I error with changing sample size n = {100, 500, 1000, 2000}.
Significance level α = 1e-04 for 105 Monte-Carlo replicates.
3 Additional plots and tables for the meta-analysis of
the Metabochip data
3.1 Procedure for adjusting False Discovery Rate
To adjust for multiple comparison of 265 genes in Metabochip data analysis, we use
Benjamini-Hochberg procedure to control the FDR at level α (Benjamini and Hochberg,
1995). The procedure can be summarized as follow:
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1. We list all m p-values in ascending order and denote them by p(1), ..., p(m).
2. For a given α, e.g., α = 0.05, we find the largest k such that p(k) ≤ kmα.
3. We reject the null hypothesis for all H(i), for i = 1, ..., k.
In Table 2, we showed the smallest insignificant p-values, i.e., p(k+1). They can be
viewed as thresholds because only p-values smaller than that can be denoted as significant.
Trait SKAT-C SKAT-A QS Burden-C Burden-A QB
HDL 1.07e-03 5.18e-03 3.99e-03 1.65e-02 1.08e-02 8.45e-04
LDL 2.24e-03 3.06e-03 1.53e-03 1.83e-03 6.01e-04 4.87e-03
CHOL 2.45e-03 8.69e-04 1.78e-03 6.13e-03 6.44e-04 1.75e-03
TG 3.26e-03 3.91e-03 5.00e-03 1.51e-03 1.16e-03 3.23e-03
Table 2: The smallest insignificant p-values (FDR < 0.05)
The significant genes after FDR adjustment are reported in Table 3.
3.2 QQ plots for the meta-analysis
We also presented the QQ plot for QS/SKAT-A QB/Burden-A p-values in meta-analysis,
see Figure 5. We observed that the p-values of QS and SKAT-A are comparable, as well as
p-values of QB and Burden-A.
3.3 Post-analysis literature research
We first present p-values of significant associations identified in Metabochip data analysis
in Table 3. To validate those genes and understand the potential biological mechanism
behind those associations, we conducted literature search. Most significant associations
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Figure 5: QQ plots for meta-analysis p values comparison, with all four traits.
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Trait Gene SKAT-C SKAT-A QS Burden-C Burden-A QB
HDL ZPR1 1.07e-03 2.53e-05 1.41e-04 6.31e-05 1.80e-05 4.30e-05
CETP 9.63e-68 1.42e-71 2.43e-59 7.62e-02 4.13e-02 1.31e-01
LPL 6.29e-08 5.47e-09 4.21e-08 2.66e-05 8.10e-06 1.42e-04
APOB 4.47e-02 7.69e-03 6.48e-04 5.47e-01 5.72e-01 1.18e-02
LDL SEC16B 1.80e-02 5.94e-03 4.37e-03 2.83e-04 3.27e-04 1.95e-05
CELSR2 2.35e-05 1.93e-05 3.02e-05 6.46e-02 1.15e-01 2.84e-01
APOC1P1 3.84e-11 1.27e-12 8.53e-12 5.03e-09 1.22e-09 4.12e-08
LDLR 1.82e-06 2.33e-06 1.58e-06 1.55e-04 6.01e-04 2.94e-04
PCSK9 3.66e-05 4.25e-05 6.69e-05 2.88e-02 2.38e-02 5.45e-02
TOMM40 9.14e-05 4.75e-05 4.87e-04 2.21e-01 2.17e-01 8.94e-01
TDRD15 2.24e-03 3.06e-03 1.75e-03 7.90e-03 4.91e-03 7.39e-04
CHOL SEC16B 2.31e-02 1.13e-01 6.07e-02 2.90e-04 3.33e-04 3.57e-05
CELSR2 3.13e-04 1.01e-04 3.28e-04 7.64e-02 8.82e-02 2.43e-01
ZPR1 7.56e-04 8.69e-04 7.15e-04 3.59e-04 6.44e-04 5.91e-04
APOC1P1 1.28e-06 3.76e-07 4.16e-07 6.05e-06 7.58e-06 9.56e-06
LDLR 5.88e-06 7.31e-06 1.62e-06 4.63e-04 2.52e-03 1.09e-04
APOB 2.45e-03 2.48e-03 2.15e-04 2.52e-02 2.14e-02 1.49e-01
PCSK9 3.78e-04 4.87e-03 1.78e-03 1.39e-02 2.48e-02 2.23e-02
TG AIDA 4.45e-04 1.91e-03 1.14e-03 3.97e-02 6.63e-02 5.03e-01
BUD13 4.48e-14 1.09e-19 2.18e-18 2.52e-02 2.11e-02 3.94e-02
ZPR1 5.44e-32 9.35e-42 6.15e-42 5.76e-36 1.28e-36 6.63e-36
APOA5 1.51e-03 1.51e-03 8.14e-04 1.51e-03 1.51e-03 8.14e-04
LPL 9.38e-15 7.45e-16 8.84e-18 6.39e-09 2.37e-08 3.51e-08
APOB 3.26e-03 1.69e-03 6.57e-04 2.05e-01 1.88e-01 1.33e-02
EIF2B4 5.09e-04 2.86e-04 5.85e-04 6.88e-02 1.48e-01 2.09e-01
IFT172 1.12e-02 1.06e-02 3.58e-02 8.58e-04 4.21e-04 7.27e-04
GCKR 3.82e-08 4.59e-08 2.86e-08 4.62e-04 1.16e-03 7.30e-04
C2orf16 1.69e-04 5.64e-05 3.20e-04 1.12e-04 4.30e-05 2.69e-04
ZNF512 6.62e-05 4.43e-06 1.34e-05 1.23e-02 7.30e-03 4.44e-04
SUPT7L 4.39e-04 2.20e-04 8.77e-05 1.94e-02 9.91e-03 5.36e-03
SLC4A1AP 6.89e-04 2.50e-04 3.69e-04 6.09e-01 5.67e-01 9.25e-01
MLXIPL 3.64e-06 1.60e-06 1.87e-06 6.86e-06 5.25e-05 1.54e-05
Table 3: Meta-analysis use FDR adjustment. The associations found only by iQRAT (QS
and QB) are denoted in red; the associations denoted in blue are not identified by iQRAT.
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have been confirmed with their corresponding traits (Table 4). Besides, there are 5 genes,
i.e., TDRD15, SEC18B, APOC1P1, AIDA and EIF2B4, have not been reported directly re-
lated with the lipid traits we analyzed. But there are evidences showed those four genes are
highly related to some lipid-related traits. For instance, though APOC1P1 is significantly
associated with LDL (Hebebrand et al., 2018), no direct evidence showing its relation to
CHOL. However, as reported in Han et al. (2018), APOC1P1 is related to coronary artery
disease, which is highly associated with lipid concentration (Willer et al., 2008). Another
interesting gene is the Axin interactor, dorsalization associated gene (AIDA). Feofanova
(2015) performed a meta-analysis of four cohorts and reported the SNP rs2378597, located
on AIDA gene, is significant for diastolic blood pressure (DBP) and systolic blood pressure
(SBP). Blood pressure is related to cardiovascular disease, and it has been shown highly
related to lipids traits (Zhang et al., 2018). Furthermore, the product of AIDA is a pe-
ripheral membrane-associated protein (Zheng et al., 2014), and AIDA is expressed in many
tissues and regulated by a family of microRNAs, mir-181. It was predicted to be associated
with coronary artery disease (Ballouz et al., 2014), based on data from the Wellcome Trust
Case Control Consortium 2007. The other two genes SEC16B and EIF2B4 are indirectly
related to lipid traits. SEC16B is highly related to body mass index (BMI), and BMI is
positively related to cholesterol (Faheem et al., 2010) as we discussed previously. The gene
EIF2B4 is related to gallbladder disease (Rodriguez et al., 2016), and Mohr et al. (1991)
already showed TG is positively related to gallbladder disease.
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Trait Gene References
HDL ZPR1 Justice et al. (2018)
CETP Kraja et al. (2011); Lu et al. (2017); Willer et al. (2008); He et al. (2018)
LPL Kraja et al. (2011); Willer et al. (2008); Lu et al. (2017)
APOB Niu et al. (2017)
LDL SEC16B highly related to BMI
(positively related to cholesterol (Faheem et al., 2010))
CELSR2 Willer et al. (2008)
APOC1P1 Hebebrand et al. (2018)
LDLR Lu et al. (2017); Willer et al. (2008); Bomba et al. (2017); He et al. (2018)
PCSK9 Lu et al. (2017); Willer et al. (2008); Bomba et al. (2017); He et al. (2018)
TOMM40 He et al. (2019)
TDRD15 related to coronary artery disease, a LDL associated disease
(Paquette et al., 2017)
CHOL SEC16B highly related to BMI
(positively related to cholesterol (Faheem et al., 2010))
CELSR2 Liu et al. (2014)
LDLR Liu et al. (2014)
APOB Niu et al. (2017)
APOC1P1 related to coronary artery disease (Han et al., 2018)
(highly associated with lipid concentration (Willer et al., 2008))
PCSK9 Teslovich et al. (2010); He et al. (2019)
TG BUD13 Kraja et al. (2011); He et al. (2018)
ZPR1 Justice et al. (2018); Speed et al. (2017); Surakka et al. (2015)
APOA5 Lu et al. (2017); Kraja et al. (2011); Willer et al. (2008)
LPL Kraja et al. (2011); Lu et al. (2017)
APOB Liu et al. (2014)
GCKR Kraja et al. (2011); Willer et al. (2008)
C2orf16 Kraja et al. (2011); Polushina et al. (2017)
ZNF512 Kraja et al. (2011); Polushina et al. (2017)
SUPT7L Zhang et al. (2018)
SLC4A1AP Zhang et al. (2018)
MLXIPL Lu et al. (2017); Willer et al. (2008)
IFT172 He et al. (2019)
AIDA affect blood pressure (Feofanova, 2015) (BP is also related to cardiovascular
disease , which is strong related to lipids traits (Zhang et al., 2018))
EIF2B4 related to gallbladder disease (Rodriguez et al., 2016)
(Mohr et al. (1991) showed TG is positively related to gallbladder disease)
Table 4: Summary for references found for significant genes discovered by both iQRAT and
SKAT-C/A. 45
4 Comparison of computational times
In Table 5, we summarize the average CPU time completing a single iQRAT using a
randomly selected 3kb region by the sample size n = {100, 500, 1000, 2000, 5000, 10000}.
n 100 500 1000 2000 5000 10000
time 0.003 0.027 0.101 0.401 2.32 10.53
Table 5: Summary for iQRAT computational time (in seconds), using a 3kb region.
5 Plots of the weight functions ϕ(·)
We present the three score (weight) functions. Recall that three weighting functions we used
are the Wilcoxon (ϕ1 = τ), Normal (ϕ2(τ) = Φ
−1(τ)), and the Lehmann score function
(ϕ3(τ) = − log(1 − τ) − 1). We plot the three score functions in Figure 6, whose first
derivatives represent the weights assigned on different quantile levels.
6 Illustration of Lehmann alternativess
We show the quantile effect of Lehmann alternatives. We compare two distributions:
G(x) = F (x)1+γ0 and F (x). The quantile effect is β(τ) = G−1(τ)−F−1(τ) = F−1(1− (1−
τ)1+γ0) − F−1(τ). For illustration purpose, we set F (x) as standard normal distribution
function Φ(·) and plot the quantile effect in Figure 7.
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